Trial Profile
A study to evaluate enzalutamide treatment in patients with metastatic castration-resistant prostate cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Dec 2015 New trial record